))
21: Sky Medical Technology Founder Speaks On Key Milestones
Manage episode 342912187 series 3305030
Treść dostarczona przez Deepbridge Capital Discovery Podcast and Deepbridge Capital. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Deepbridge Capital Discovery Podcast and Deepbridge Capital lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Bernard Ross (CEO & Founder of Sky Medical Technolgoy) joins the Deepbridge Discovery Podcast to discuss the challenges he has faced, including the impact of a global pandemic, the next steps and goals for Sky Medical Technology and the advice he would give to entrepreneurs, particularly in the medical technology sector.
About Sky Medical Technology:
Sky Medical develops bioelectronic devices integrated with OnPulse neuromodulation technology to prevent and treat a wide range of acute and chronic circulatory conditions (e.g. to prevent venous thromboembolism (VTE), to prevention and reduction of edema after surgery, to heal venous and arterial leg ulcers as well as chronic wounds, and speed-up recovery time for high-performance athletes.
After conducting further clinical research, OnPulse is now being used in hospitals and in community care centers to accelerate patient recovery after surgery and to accelerate healing of chronic venous and diabetic ulcers. Devices are also used by Olympic and USA professional athletes such as the US Olympic Hockey team and NFL, MLS, MLB, NBA, D1 NCAA teams, and NHL clubs to accelerate post training and post-match recovery. Teams include but are not limited to AC Milan, Chelsea, West Ham, Everton football teams, Golden State Warriors, New England Patriots and the San Francisco 49ers.
By stimulating the peroneal nerve using neuromodulation, we believe we can create a natural effect within the body that will improve function and quality of life for patients.
- - -
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
About Sky Medical Technology:
Sky Medical develops bioelectronic devices integrated with OnPulse neuromodulation technology to prevent and treat a wide range of acute and chronic circulatory conditions (e.g. to prevent venous thromboembolism (VTE), to prevention and reduction of edema after surgery, to heal venous and arterial leg ulcers as well as chronic wounds, and speed-up recovery time for high-performance athletes.
After conducting further clinical research, OnPulse is now being used in hospitals and in community care centers to accelerate patient recovery after surgery and to accelerate healing of chronic venous and diabetic ulcers. Devices are also used by Olympic and USA professional athletes such as the US Olympic Hockey team and NFL, MLS, MLB, NBA, D1 NCAA teams, and NHL clubs to accelerate post training and post-match recovery. Teams include but are not limited to AC Milan, Chelsea, West Ham, Everton football teams, Golden State Warriors, New England Patriots and the San Francisco 49ers.
By stimulating the peroneal nerve using neuromodulation, we believe we can create a natural effect within the body that will improve function and quality of life for patients.
- - -
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
48 odcinków
Udostępnij
